Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Gerontology
|
January 1, 1984
The effect of age on central and regional hemodynamics
M E Leithe, J B Hermiller, R D Magorien, et al.
Seminars in Oncology
|
March 1, 1983
N-acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP
D V Unverferth, R H Fertel, S P Balcerzak, et al.
Chest
|
June 1, 1982
The effect of vasodilator therapy on systolic and diastolic time intervals in congestive heart failure
C V Leier, R D Magorien, H Boudoulas, et al.
Cancer Treatment Reports
|
November 1, 1981
Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration
D V Unverferth, R D Magorien, B P Unverferth, et al.
American Heart Journal
|
July 1, 1983
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
D V Unverferth, R D Magorien, R Altschuld, et al.
Gerontology
|
January 1, 1986
Aging of the human myocardium: a histologic study based upon endomyocardial biopsy
D V Unverferth, P B Baker, A R Arn, et al.
Catheterization and Cardiovascular Diagnosis
|
January 1, 1981
Biochemical measurements of endomyocardial biopsies
D V Unverferth, R H Fertel, R Altschuld, et al.
Journal of the National Cancer Institute
|
November 1, 1983
Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine
D V Unverferth, J M Jagadeesh, B J Unverferth, et al.
Circulation
|
March 1, 1982
Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure
R D Magorien, G P Brown, D V Unverferth, et al.
Annals of Internal Medicine
|
July 1, 1981
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose
R D Magorien, D W Triffon, C E Desch, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Gerontology
|
January 1, 1984
The effect of age on central and regional hemodynamics
M E Leithe, J B Hermiller, R D Magorien, et al.
Seminars in Oncology
|
March 1, 1983
N-acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP
D V Unverferth, R H Fertel, S P Balcerzak, et al.
Chest
|
June 1, 1982
The effect of vasodilator therapy on systolic and diastolic time intervals in congestive heart failure
C V Leier, R D Magorien, H Boudoulas, et al.
Cancer Treatment Reports
|
November 1, 1981
Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration
D V Unverferth, R D Magorien, B P Unverferth, et al.
American Heart Journal
|
July 1, 1983
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
D V Unverferth, R D Magorien, R Altschuld, et al.
Gerontology
|
January 1, 1986
Aging of the human myocardium: a histologic study based upon endomyocardial biopsy
D V Unverferth, P B Baker, A R Arn, et al.
Catheterization and Cardiovascular Diagnosis
|
January 1, 1981
Biochemical measurements of endomyocardial biopsies
D V Unverferth, R H Fertel, R Altschuld, et al.
Journal of the National Cancer Institute
|
November 1, 1983
Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine
D V Unverferth, J M Jagadeesh, B J Unverferth, et al.
Circulation
|
March 1, 1982
Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure
R D Magorien, G P Brown, D V Unverferth, et al.
Annals of Internal Medicine
|
July 1, 1981
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose
R D Magorien, D W Triffon, C E Desch, et al.
Page
of 7